Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Maruho Co. Ltd.
Molecular Target Transient receptor potential A1 (TRPA1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
PartnerSumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today